title: Tardive blepharospasm associated with cinnarizine use.
abstract: OBJECTIVE
  To report a patient with chronic blepharospasm possibly induced by the calcium-channel blocker cinnarizine.
  
  
  METHODS
  A 53-year-old woman developed chronic blepharospasm during a prolonged therapy with calcium-channel blocker cinnarizine for the treatment of vertigo.
  
  
  CONCLUSIONS
  "Tardive blepharospasm" should be considered as a possible adverse effect of cinnarizine.
authors.affiliation: Sección de Neurología, Hospital Virgen de la Concha, Zamora, and Departamento de Medicina-Neurología, Hospital Príncipe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
authors.forename: Hortensia
authors.initials: H
authors.lastname: Alonso-Navarro
authors.forename: Félix Javier
authors.initials: FJ
authors.lastname: Jiménez-Jiménez
mesh_terms: D001764:Blepharospasm / Q000139:chemically induced*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D002936:Cinnarizine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged
chemical_list: D002121:Calcium Channel Blockers; D002936:Cinnarizine